“Hepatitis b”的搜索结果，显示 121-130 项，共有 9524 项

1. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

2. 外科 - 医生 - 妙佑医疗国际

   Hepatitis C, Hepatitis B, Hepatocellular carcinoma, Nonalcoholic fatty liver disease, Cirrhosis, Alcoholic hepatitis, H...epatic encephalopathy, Portal ...

3. 肝癌 - 症状与病因- 妙佑医疗国际

   Hepatitis B questions and answers for the public. Centers for Disease Control and Prevention. https://www.cdc.gov/hepatitis/hbv/bfaq.htm. Accessed March 4 ...

4. 神经内分泌肿瘤- 医生与科室- 妙佑医疗国际

   M.B.B.S.. Transplant Hepatologist. Rochester, MN. 擅长领域：. Cholangiocarcinoma, Primary sclerosing cholangitis, Hepatitis C, Hepatitis B, Hepatocellular ...

5. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

6. 皮肤 B 细胞淋巴瘤- 分期 - 妙佑医疗国际

   详细了解此类非霍奇金淋巴瘤的症状、诊断和治疗方法。

7. 丙肝 - 在 Mayo Clinic 治疗 - 妙佑医疗国际

   Mayo Clinic 新闻. Mayo Clinic Q and A: Understanding hepatitis C. 产品与服务. 书籍：《妙佑医疗国际消化健康医护指南》 · 妙佑医疗国际明尼苏达州罗切斯特院区已被 ...

8. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

9. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

10. 妙佑医疗国际 - 概述

    皮肤B 细胞淋巴瘤是一种罕见癌症，始发于白细胞。这种癌症会侵袭皮肤。皮肤B 细胞淋巴瘤始发于一种称为B 细胞的抗菌白细胞。这些细胞又称为B 淋巴细胞。